SLC2A2 and diabetic kidney disease: These results are in agreement with our previous findings, demonstrating that peripheral pharmacological blockade of CB1R ameliorates DKD in Akita and in streptozotocin (STZ)-induced diabetic mice via downregulating GLUT2 expression and its dynamic translocation25.